Unicycive Therapeutics, Inc. (UNCY) Capital expenditures 2021–2025
Unicycive Therapeutics, Inc. (UNCY) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$24,000FY2025 · since FY2021: $29,000 → $24,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $24,000 | -66.7% |
| FY2024 | $72,000 | +500.0% |
| FY2023 | $12,000 | +500.0% |
| FY2022 | $2,000 | -93.1% |
| FY2021 | $29,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice